TrialScience translational medicine2025

Vaccination with mRNA-encoded membrane-anchored HIV envelope trimers elicited tier 2 neutralizing antibodies in a phase 1 clinical trial.

K Rachael Parks et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.